Monthly Archives: November 2023

Recent Studies Explore the Link Between Cannabis Use and Increased Cardiovascular Risks

Two recent studies investigated the connections between cannabis use and developing certain heart conditions. On November 6th, 2023, the American Heart Association (AHA) released results from two studies from different research groups on the risk of cannabis use and developing heart issues, particularly heart attack and heart failure (1). The two studies were poster abstracts […]

Castle Biosciences Announces Multiple Data Presentations at the 2023 American Society for Dermatologic Surgery Annual Meeting

Video abstracts reinforce the clinical validity and utility of the Company’s skin cancer test portfolio, including DecisionDx®-Melanoma, DecisionDx®-SCC and MyPath® Melanoma FRIENDSWOOD, Texas–(BUSINESS WIRE)– Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that data spanning its dermatologic portfolio of gene expression profile (GEP) tests was […]

Opinion | No, Immigrants Aren’t ‘Poisoning the Blood of Our Country’

Does Donald Trump ever visit Queens, the land of his youth? If he did, he would presumably be horrified. According to the census, Queens is the most racially and ethnically diverse county in the continental United States; it’s hard to think of a nationality or culture that isn’t represented there. Immigrants are almost half the […]

Racial disparities between measures of area deprivation and financial toxicity, and uterine volume in myomectomy patients

Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501–12. Article  CAS  PubMed  Google Scholar  Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7. Article  PubMed  Google Scholar  Kim […]

$72 Million Funds Neoantigen-based Cancer Vaccine Candidates

(Precision Vaccinations News) Nouscom recently announced the completion of its Series C equity financing, raising $72 million that will be used to continue advancing and expanding Nouscom’s wholly-owned clinical pipeline to achieve multiple clinical value catalysts. As of November 13, 2023, the funding proceeds will support the following initiatives: Readout from Nouscom’s ongoing randomized Phase 2 […]

ABO and Rh blood groups and risk of infection: systematic review and meta-analysis

A total of 419 articles were identified through the database searches, and 57 duplicates were removed. The titles and abstracts of the remaining 362 articles were screened, of which 219 were excluded at this phase. One hundred and forty-three articles underwent full-text review, of which 82 were then excluded at this next phase. The references […]

Top in ID: Novel procedure for lung infection; leftover antibiotics threaten stewardship

November 14, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . <button type="button" class="btn btn-primary" data-loading-text="Loading ” data-action=”subscribe”> Subscribe Added to email alerts We were unable to process your request. […]

Clomiphene citrate plus letrozole versus clomiphene citrate alone for ovulation induction in infertile women with ovulatory dysfunction: a randomized controlled trial

Study design and overview This study employed a randomized controlled trial design. It was conducted at the Infertility and Reproductive Biology Unit of the Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, from November 2020 to December 2021. Eligible participants were randomly allocated to a “combination group” or a […]

Acinetobacter spp. bloodstream infection in hematological patients: a 10-year single-center study

Clinical characteristics and outcomes Complete clinical data were obtained from 40 patients with Acinetobacter spp. BSI during the study period. The clinical characteristics of patients with Acinetobacter spp. BSI who survived or died within 30 days are summarised in Table 1. The sex distribution was similar between the groups, with a median age of 25.5 years […]